Sticking With This Ocular Therapeutix Price Target as Key Treatment Moves Forward
The small-cap healthcare firm offered some encouraging earnings results.
Adding to a Couple of Troubled Positions as July Comes to a Close
Here’s our trading plan for Friday and the upcoming earnings calendar for portfolio names.
Cutting SoFi as ‘Misleading’ Report Continues to Weight on Share Price
The financial services firm has taken a turn for the worse.
Our Small-Cap Drone Name Faces Opportunity After DoD Ramp Up Report
Though shares on under pressure on the news, there’s no long-term concern.
Selling 5 Small-Cap Names for a LIFO Profit
We looked to take advantage of some pre-earnings weakness and now we’re ready to profit.
5 Stocks We Want to Buy on Weakness Ahead of Earnings
Here’s our shopping list for Friday as well as the latest portfolio news.
The $10K Portfolio’s Fueling Up on Rocket Lab (And Another Stock)
Here’s the plan for Rocket Lab; also, another stock we’re stocking up on today.
Our Small-Cap Defense Name Surges After $70 Million Update
Plus, SoFi is set to release some important earnings data.
Why I’m Not Chasing AMC’s Odyssey
Here’s the latest on our Ocular Therapeutix trading strategy, a planned purchase for today and some additional portfolio news.
Our Ocular Call Is Set to Expire as Market Struggles
We’re a bit handcuffed when it comes to making moves in our small-cap portfolio.